Dublin Scientists Team with Agilent to Develop 2D LC Separation Platform for Glycan Research
July 09, 2010
Dublin Scientists Team with Agilent to Develop 2D LC Separation Platform for Glycan Research
The platform will be based on Agilent's HPLC-chip technology and will enable high-throughput, nanoscale analysis of N-glycosylated proteins, said a researcher at Dublin's National Institute for Bioprocessing Research and Training.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Instrument Vendors Focus on UPLC and Triple-Quad, Qual-Quan MS at JP Morgan Conference
January 14, 2011 / ProteoMonitor - Proteomics Expectations Bear Fruit in 2010, But Challenges Remain
January 7, 2011 / ProteoMonitor - Waters Says Switching to UHPLC Could Trigger Significant Growth In Instrument Business
October 29, 2010 / ProteoMonitor - Major Mass Spec Vendors Highlight New Offerings at UBS Global Life Sciences Conference
September 24, 2010 / ProteoMonitor - New LC Releases Emphasize Cross-Platform Compatibility, Bio-Inert Capabilities
June 25, 2010 / ProteoMonitor